Pharmacodynamics and proteomic analysis of acalabrutinib therapy: Similarity of on-target effects to ibrutinib and rationale for combination therapy

Pharmacodynamics and proteomic analysis of acalabrutinib therapy: Similarity of on-target effects to ibrutinib and rationale for combination therapyPharmacodynamics and proteomic analysis of acalabrutinib therapy: Similarity of on-target effects to ibrutinib and rationale for combination therapy, Published online: 03 November 2017; doi:10.1038/leu.2017.321

Source: Leukemia - November 3, 2017 Category: Hematology Authors: V K Patel B Lamothe M L Ayres J Gay J Cheung K Balakrishnan C Ivan J Morse M Nelson M J Keating W G Wierda J R Marszalek V Gandhi Source Type: research